|
Market Closed -
BME
09:05:01 12/08/2026 pm IST
|
After hours 01:29:56 am | |||
| 57.80 EUR | -0.94% |
|
57.98 | +0.30% |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 23/07 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 344.36Cr | |||||
| 1,08300Cr | |||||
| 63TCr | - | - | - | ||
| 44TCr | |||||
| 36TCr | |||||
| 29TCr |
Select your edition
All financial news and data tailored to specific country editions
